Literature DB >> 1552616

Citraturic response to oral citric acid load.

K Sakhaee1, R Alpern, J Poindexter, C Y Pak.   

Abstract

It is possible that some orally administered citrate may appear in urine by escaping oxidation in vivo. To determine whether this mechanism contributes to the citraturic response to potassium citrate, we measured serum and urinary citrate for 4 hours after a single oral load of citric acid (40 mEq.) in 6 normal subjects. Since citric acid does not alter acid-base balance, the effect of absorbed citrate could be isolated from that of alkali load. Serum citrate concentration increased significantly (p less than 0.05) 30 minutes after a single oral dose of citric acid and remained significantly elevated for 3 hours after citric acid load. Commensurate with this change, urinary citrate excretion peaked at 2 hours and gradually decreased during the next 2 hours after citric acid load. In contrast, serum and urinary citrate remained unaltered following the control load (no drug). Differences of the citratemic and citraturic effects between phases were significant (p less than 0.05) at 2 and 3 hours. Urinary pH, carbon dioxide pressure, bicarbonate, total carbon dioxide and ammonium did not change at any time after citric acid load, and did not differ between the 2 phases. No significant difference was noted in serum electrolytes, arterialized venous pH and carbon dioxide pressure at any time after citric acid load and between the 2 phases. Thus, the citraturic and citratemic effects of oral citric acid are largely accountable by provision of absorbed citrate, which has escaped in vivo degradation.

Entities:  

Keywords:  NASA Discipline Regulatory Physiology; Non-NASA Center

Mesh:

Substances:

Year:  1992        PMID: 1552616     DOI: 10.1016/s0022-5347(17)37437-2

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  12 in total

1.  Prophylactic and therapeutic properties of a sodium citrate preparation in the management of calcium oxalate urolithiasis: randomized, placebo-controlled trial.

Authors:  Shameez Allie-Hamdulay; Allen L Rodgers
Journal:  Urol Res       Date:  2005-05-04

2.  Can lemon juice be an alternative to potassium citrate in the treatment of urinary calcium stones in patients with hypocitraturia? A prospective randomized study.

Authors:  Bekir Aras; Nadir Kalfazade; Volkan Tuğcu; Eray Kemahli; Bedi Ozbay; Hakan Polat; Ali Ihsan Taşçi
Journal:  Urol Res       Date:  2008-10-23

3.  CUA guideline on the evaluation and medical management of the kidney stone patient - 2016 update.

Authors:  Marie Dion; Ghada Ankawi; Ben Chew; Ryan Paterson; Nabil Sultan; Patti Hoddinott; Hassan Razvi
Journal:  Can Urol Assoc J       Date:  2016-11-10       Impact factor: 1.862

4.  In vitro anti-lithogenic activity of lime powder regimen (LPR) and the effect of LPR on urinary risk factors for kidney stone formation in healthy volunteers.

Authors:  Pajaree Chariyavilaskul; Poonsin Poungpairoj; Suchada Chaisawadi; Chanchai Boonla; Thasinas Dissayabutra; Phisit Prapunwattana; Piyaratana Tosukhowong
Journal:  Urolithiasis       Date:  2015-01-15       Impact factor: 3.436

5.  Organic acid bioavailability from banana and sweet potato using an in vitro digestion and Caco-2 cell model.

Authors:  Houda Sabboh-Jourdan; Fanny Valla; Indah Epriliati; Michael J Gidley
Journal:  Eur J Nutr       Date:  2010-04-29       Impact factor: 5.614

6.  rs11567842 SNP in SLC13A2 gene associates with hypocitraturia in Thai patients with nephrolithiasis.

Authors:  Pattarin Udomsilp; Sarawut Saepoo; Rungnapa Ittiwut; Vorasuk Shotelersuk; Thasinas Dissayabutra; Chanchai Boonla; Piyaratana Tosukhowong
Journal:  Genes Genomics       Date:  2018-05-17       Impact factor: 1.839

7.  Prevention of renal crystal deposition by an extract of Ammi visnaga L. and its constituents khellin and visnagin in hyperoxaluric rats.

Authors:  P Vanachayangkul; N Chow; S R Khan; Veronika Butterweck
Journal:  Urol Res       Date:  2010-11-11

8.  Impact of Potassium Citrate vs Citric Acid on Urinary Stone Risk in Calcium Phosphate Stone Formers.

Authors:  Steeve Doizi; John R Poindexter; Margaret S Pearle; Francisco Blanco; Orson W Moe; Khashayar Sakhaee; Naim M Maalouf
Journal:  J Urol       Date:  2018-07-20       Impact factor: 7.450

9.  Identification of transport pathways for citric acid cycle intermediates in the human colon carcinoma cell line, Caco-2.

Authors:  Jittima Weerachayaphorn; Ana M Pajor
Journal:  Biochim Biophys Acta       Date:  2007-12-23

10.  Hypocitraturia: pathophysiology and medical management.

Authors:  Jack M Zuckerman; Dean G Assimos
Journal:  Rev Urol       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.